Triple-negative breast cancer (TNBC) was first identified by Perou and Sorlie of Stanford University and was defined as tumors that do not express estrogen receptor (ER), progesterone receptor (PR) and HER2. Here, ERBB2 is linked to triple-negative breast carcinoma.